Ando T - Search Results

1

Epstein-Barr virus-associated lymphoproliferative disease during remission after induction therapy with dasatinib in Philadelphia chromosome-positive acute lymphoblastic leukemia: a case report.

Sugihara A, Kubota Y, Nagaie T, Fujita M, Ishii K, Okamoto S, Ureshino H, Katsuya H, Takeuchi M, Kai K, Ando T, Ohshima K, Kimura S. Sugihara A, et al. Among authors: ando t. Ann Hematol. 2024 Dec 21. doi: 10.1007/s00277-024-06153-5. Online ahead of print. Ann Hematol. 2024. PMID: 39708159

2

Epstein-Barr virus-positive diffuse large B cell lymphoma, not otherwise specified, carrying a t(19;22)(q13;q11) translocation.

Yamaguchi K, Kubota Y, Kishimori C, Ohno H, Kidoguchi K, Kizuka-Sano H, Nishioka A, Katsuya H, Ando T, Kimura S. Yamaguchi K, et al. Among authors: ando t. Ann Hematol. 2020 Feb;99(2):389-390. doi: 10.1007/s00277-019-03898-2. Epub 2019 Dec 17. Ann Hematol. 2020. PMID: 31848683 No abstract available.

3

A methotrexate-associated lymphoproliferative disorder expressing CD10 and BCL6 with the IGH/CCND1 translocation.

Katsuya H, Kizuka-Sano H, Yokoo M, Kidoguchi K, Yamaguchi K, Nishioka A, Ureshino H, Kubota Y, Ando T, Naito S, Ohshima K, Kimura S. Katsuya H, et al. Among authors: ando t. Ann Hematol. 2020 Oct;99(10):2449-2451. doi: 10.1007/s00277-020-04218-9. Epub 2020 Aug 26. Ann Hematol. 2020. PMID: 32851455 No abstract available.

4

Efficacy and safety of ponatinib for patients with Philadelphia chromosome-positive acute lymphoblastic leukemia: a case series from a single institute.

Kidoguchi K, Ureshino H, Kizuka-Sano H, Yamaguchi K, Katsuya H, Kubota Y, Ando T, Miura M, Takahashi N, Kimura S. Kidoguchi K, et al. Among authors: ando t. Int J Hematol. 2021 Aug;114(2):199-204. doi: 10.1007/s12185-021-03156-0. Epub 2021 Apr 27. Int J Hematol. 2021. PMID: 33907977

5

Coexistence of ALK-anaplastic large cell lymphoma and CD4+ T cell large granular lymphocytic leukemia.

Kamachi K, Fukushima N, Ando T, Sato K, Ohshima K, Yokoo M, Shindo T, Kubota Y, Kojima K, Kimura S. Kamachi K, et al. Among authors: ando t. Ann Hematol. 2015 Mar;94(3):539-40. doi: 10.1007/s00277-014-2176-z. Epub 2014 Aug 8. Ann Hematol. 2015. PMID: 25100004 No abstract available.

6

Reactivation of resolved infection with the hepatitis B virus immune escape mutant G145R during dasatinib treatment for chronic myeloid leukemia.

Ando T, Kojima K, Isoda H, Eguchi Y, Honda T, Ishigami M, Kimura S. Ando T, et al. Int J Hematol. 2015 Sep;102(3):379-82. doi: 10.1007/s12185-015-1788-y. Epub 2015 Apr 5. Int J Hematol. 2015. PMID: 25842192

7

Subdural Hematoma Associated with Dasatinib and Intrathecal Methotrexate Treatment in Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia.

Ureshino H, Nishioka A, Kojima K, Kizuka H, Sano H, Shindo T, Kubota Y, Ando T, Kimura S. Ureshino H, et al. Among authors: ando t. Intern Med. 2016;55(18):2703-6. doi: 10.2169/internalmedicine.55.6966. Epub 2016 Sep 15. Intern Med. 2016. PMID: 27629971 Free article.

8

5q- syndrome-like features as the first manifestation of myelodysplastic syndrome in a patient with an unbalanced whole-arm translocation der(5;19)(p10;q10).

Ureshino H, Kizuka H, Kusaba K, Sano H, Nishioka A, Shindo T, Kubota Y, Ando T, Kojima K, Kimura S. Ureshino H, et al. Among authors: ando t. Int J Hematol. 2017 May;105(5):692-696. doi: 10.1007/s12185-016-2160-6. Epub 2016 Dec 2. Int J Hematol. 2017. PMID: 27914067 Review.

9

Elderly Patients With Chronic Myeloid Leukemia Benefit From a Dasatinib Dose as Low as 20 mg.

Itamura H, Kubota Y, Shindo T, Ando T, Kojima K, Kimura S. Itamura H, et al. Among authors: ando t. Clin Lymphoma Myeloma Leuk. 2017 Jun;17(6):370-374. doi: 10.1016/j.clml.2017.02.023. Epub 2017 Mar 18. Clin Lymphoma Myeloma Leuk. 2017. PMID: 28396095

10

Tocilizumab for severe cytokine-release syndrome after haploidentical donor transplantation in a patient with refractory Epstein-Barr virus-positive diffuse large B-cell lymphoma.

Ureshino H, Ando T, Kizuka H, Kusaba K, Sano H, Nishioka A, Itamura H, Shindo T, Kubota Y, Kojima K, Kimura S. Ureshino H, et al. Among authors: ando t. Hematol Oncol. 2018 Feb;36(1):324-327. doi: 10.1002/hon.2481. Epub 2017 Oct 3. Hematol Oncol. 2018. PMID: 28971493

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,495 results

Search Page

Filters